Full video transcriptClick to expand
Auto-generated transcript of @garrettwayne0's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00My biggest problem with peptides like Cilank is that people will use them and
- 0:06In hopes to cure their depression or make themselves not feel anxious or anything like that, right?
- 0:13But the problem is is that you are feeling depressed
- 0:17You are feeling all of this anxiousness because of the environment that you are in
- 0:22there are circumstances going on in your life and
- 0:25And there are things that you are thinking mentally that I've put you into that bubble
- 0:32So unless you fix your circumstances around you unless you try to make change
- 0:38Your state of mind is not going to change. I'm not saying don't use it
- 0:43But I'm saying at the end of the day you need to fix your wound cause and what fixed that for me was Jesus
- 0:49And I hope you guys can seek him you do not choose to do so. I pray that you can
- 0:55Get out of that situation because I know that it sucks
Selank on TikTok: separating Soviet-era research from hype
Quick answer
Selank is a synthetic anxiolytic peptide with a limited but non-zero evidence base, primarily from Russian clinical research, suggesting modest effects on anxiety through GABAergic and BDNF-related pathways. The creator's argument that environmental circumstances drive depression is supported by biopsychosocial models of mental illness, but their framing underweights the neurobiological dimensions of mood disorders. Selank is not FDA-approved, is not a recognized treatment for any psychiatric condition in US clinical guidelines, and should not be positioned as a replacement for evidence-based mental health care.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Selank on TikTok: separating Soviet-era research from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Selank on TikTok: separating Soviet-era research from hype is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Selank on TikTok: separating Soviet-era research from hype" from Garrett. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Selank is a synthetic anxiolytic peptide with a limited but non-zero evidence base, primarily from Russian clinical research, suggesting modest effects on anxiety through GABAergic and BDNF-related pathways.
The reason this review is not generic is the source wording and the canonical claim label "peptides peptide selank." In this clip, the useful excerpt is: "My biggest problem with peptides like Cilank is that people will use them and In hopes to cure their depression or make themselves not feel anxious or anything like that, right?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Selank is a synthetic anxiolytic peptide with a limited but non-zero evidence base, primarily from Russian clinical research, suggesting modest effects on anxiety through GABAergic and BDNF-related pathways.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Selank is a synthetic anxiolytic peptide with a limited but non-zero evidence base, primarily from Russian clinical research, suggesting modest effects on anxiety through GABAergic and BDNF-related pathways. The creator's argument that environmental circumstances drive depression is supported by biopsychosocial models of mental illness, but their framing underweights the neurobiological dimensions of mood disorders. Selank is not FDA-approved, is not a recognized treatment for any psychiatric condition in US clinical guidelines, and should not be positioned as a replacement for evidence-based mental health care.
- Selank is not FDA-approved for depression, anxiety, or any psychiatric indication in the United States.
- The most robust existing trial on selank for anxiety (Zozulya et al., 2001) involved a small patient sample and has not been widely replicated in Western peer-reviewed literature.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Selank is not FDA-approved for depression, anxiety, or any psychiatric indication in the United States.
- The most robust existing trial on selank for anxiety (Zozulya et al., 2001) involved a small patient sample and has not been widely replicated in Western peer-reviewed literature.
- CBT outperforms or matches pharmacological treatment for generalized anxiety disorder long-term, per Hofmann and Smits (2008, Journal of Clinical Psychiatry), supporting the creator's broader point about addressing root causes.
- The biopsychosocial model confirms environmental factors contribute to depression, but genetics, neurobiology, and physiology also play documented roles that a purely circumstantial explanation ignores.
- Compounded or gray-market selank products are not subject to FDA quality controls, meaning purity and dosing accuracy are not guaranteed.
- Using any anxiolytic substance, peptide or pharmaceutical, without concurrent psychological or lifestyle intervention is associated with worse long-term outcomes than combined approaches.
- If depression or anxiety is severe enough to drive someone toward unregulated peptide research, that symptom severity warrants evaluation by a licensed mental health provider, not a peptide protocol.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @garrettwayne0 actually say?
The creator argues that people using "Cilank" (selank) to treat depression or anxiety are missing the point. Their core claim: depression and anxiety are products of your environment, circumstances, and thought patterns, not a brain chemistry problem a peptide can solve. They stop short of saying don't use it, but the message is clear, selank is a bandage, not a fix. The actual fix, they say, was Jesus.
This is not really a video about selank's pharmacology. It's a philosophy-of-healing argument dressed in peptide language. That matters for how we evaluate it, because some parts of the underlying logic have real scientific grounding, and some do not.
Does the science back this up?
Partially, yes. The idea that external circumstances drive mental health struggles has strong support. But the claim that depression and anxiety are purely environmental, with no neurobiological component, is an oversimplification the research does not support.
Selank itself is a synthetic heptapeptide derived from tuftsin, originally developed in Russia and studied primarily by the Institute of Molecular Genetics in Moscow. Animal studies and a handful of small human trials suggest anxiolytic effects, possibly through modulation of GABA-A receptors and brain-derived neurotrophic factor (BDNF) expression. Zozulya et al. (2001, Bulletin of Experimental Biology and Medicine) found selank reduced anxiety in patients with generalized anxiety disorder in a small controlled trial. That's real data, but it is limited, not replicated widely in Western peer-reviewed literature, and far from enough to draw firm clinical conclusions.
On the environmental side, the biopsychosocial model of depression, supported by decades of research including Kendler et al. (2006, American Journal of Psychiatry), confirms that life stressors and social circumstances meaningfully contribute to depressive episodes. The creator is not wrong about that piece.
What did they get wrong (or right)?
They got one thing meaningfully right: using any anxiolytic, peptide or pharmaceutical, without addressing underlying life circumstances is a recipe for dependency on a crutch. That is a defensible clinical perspective. Psychologists call it the difference between symptom management and root-cause work.
What they got wrong is the implicit claim that depression and anxiety are fundamentally environmental and volitional problems. That framing erases people with generalized anxiety disorder, major depressive disorder, or treatment-resistant depression, conditions with documented neurobiological underpinnings. Saying someone is depressed because of "things that you are thinking mentally" edges dangerously close to the discredited idea that mental illness is a mindset problem you can just fix.
They also do not address that selank has a real, if limited, evidence base for anxiety specifically. Dismissing it as a solution to a wound you haven't treated is not the same as saying it has no legitimate role in a broader treatment plan. Nuance matters here, and the video skips it.
What should you actually know?
Selank is not approved by the FDA for any indication. It is not a cure for depression or anxiety, and no responsible clinician would frame it that way. The existing studies are small, mostly Russian-origin, and not sufficient to establish it as a first-line or standalone treatment for any diagnosed mental health condition.
That said, the creator's instinct that peptides are sometimes used as shortcuts around harder psychological work is worth taking seriously. Research on anxiety treatment consistently shows that cognitive behavioral therapy outperforms or matches pharmacological intervention for generalized anxiety disorder over the long term, per Hofmann and Smits (2008, Journal of Clinical Psychiatry).
If you are experiencing depression or anxiety severe enough that you are researching peptides as a solution, the most evidence-supported step is talking to a licensed mental health provider, not sourcing a research peptide. Selank is not regulated as a drug in the US, quality and purity of available products vary significantly, and the absence of FDA oversight means you are taking on real unknowns. A peptide is not a substitute for therapy, medication when clinically indicated, or the kind of life changes the creator is actually advocating for.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Garrett · TikTok creator
4.0K views on this video
#peptide #selank
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about selank?
Selank is not FDA-approved for depression, anxiety, or any psychiatric indication in the United States.
What does the video say about the most robust existing trial on selank for anxiety (zozulya?
The most robust existing trial on selank for anxiety (Zozulya et al., 2001) involved a small patient sample and has not been widely replicated in Western peer-reviewed literature.
What does the video say about cbt outperforms?
CBT outperforms or matches pharmacological treatment for generalized anxiety disorder long-term, per Hofmann and Smits (2008, Journal of Clinical Psychiatry), supporting the creator's broader point about addressing root causes.
What does the video say about the biopsychosocial model confirms environmental factors contribute to depression,?
The biopsychosocial model confirms environmental factors contribute to depression, but genetics, neurobiology, and physiology also play documented roles that a purely circumstantial explanation ignores.
What does the video say about compounded?
Compounded or gray-market selank products are not subject to FDA quality controls, meaning purity and dosing accuracy are not guaranteed.
What does the video say about using any anxiolytic substance, peptide?
Using any anxiolytic substance, peptide or pharmaceutical, without concurrent psychological or lifestyle intervention is associated with worse long-term outcomes than combined approaches.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Garrett, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.